Breaking News
Get 40% Off 0
☕ Buy the dip? After losing 17%, Starbucks sees an estimated 20% upside. See the top Undervalued stocks! Unlock list
Close

Valerio Therapeutics SA (ALVIO)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.1130 +0.0042    +3.86%
09:59:17 - Real-time Data. Currency in EUR ( Disclaimer )
  • Volume: 11,392
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 0.1082 - 0.1160
Type:  Equity
Market:  France
ISIN:  FR0010095596 
Valerio Therapeutics 0.1130 +0.0042 +3.86%

Valerio Therapeutics Company Profile

 
Read the BioAlliance company profile to learn more about the business and the management team. View Valerio Therapeutics SA facts about employee data, company products and services, and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

25

Equity Type

ORD

Valerio Therapeutics Société anonyme, a clinical-stage biotechnology company, designs and develops oncology drugs for tumor DNA repair functions worldwide. The company offers Beleodaq for the treatment of peripheral T-cell lymphoma. It also develops AsiDNA, which is in Phase 1 clinical trial for the treatment of metastatic melanoma; OX401, which is in preclinical stage for treating DNA damage response and immuno-oncology; and platON, a decoy oligonucleotide platform. It has a license agreement with Acrotech Biopharma LLC; and clinical research agreement with Gustave Roussy to conduct clinical trial of AsiDNA for the treatment of relapsed ovarian cancer. The company was formerly known as Onxeo SA and changed its name to Valerio Therapeutics Société anonyme in June 2023. Valerio Therapeutics Société anonyme was incorporated in 1997 and is headquartered in Paris, France.

Contact Information

Address 49, Bd du Général Martial Valin
Paris, 75015
France
Phone 33 1 45 58 76 00
Fax 33 1 45 58 08 81

Top Executives

Name Age Since Title
Nicolas Trebouta 60 2011 Representative Director
Gilbert Chu - 2021 Member of Scientific Advisory Committee
Gilles Favre - 2021 Member of Scientific Advisory Committee
Bryan Giraudo 48 2021 Independent Director
Julien Miara 40 2020 Director
Ruth Plummer - 2021 Member of Scientific Advisory Committee
Shefali Agarwal 50 2021 President, CEO & Chairwoman
Robert L. Coleman 62 2021 Independent Director
Lorenzo Galluzzi - 2021 Member of Scientific Advisory Committee
Caroline Robert - 2021 Member of Scientific Advisory Committee
Jacques Mallet 63 2021 Independent Director
Khalil Barrage 58 2022 Representative Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ALVIO Price Commentary

Write your thoughts about Valerio Therapeutics SA
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email